4.6 Article

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

Journal

SUPPORTIVE CARE IN CANCER
Volume 27, Issue 10, Pages 3849-3857

Publisher

SPRINGER
DOI: 10.1007/s00520-019-04680-w

Keywords

Survivorship; Balance training; Resistance training; Aerobic training; Neurophysiology

Funding

  1. Cancer Institute NSW Program Grant [14/TPG/1-05]
  2. National Health and Medical Research Council of Australia (NHMRC) [1080521]
  3. NHMRC Career Development Fellowship [1148595]
  4. National Health and Medical Research Council of Australia [1148595] Funding Source: NHMRC

Ask authors/readers for more resources

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and is associated with functional deficits and an increased falls incidence. There are presently no strongly recommended treatment strategies for CIPN. The aim of this study was to evaluate the impact of a multimodal exercise intervention on CIPN symptoms and related functional deficits, as well as neurophysiologic parameters. Methods All outcomes were assessed before and after an 8-week exercise intervention (3-weekly sessions) and preceding 8-week control period at baseline, pre-exercise and post-exercise. Outcome measures were objective and patient-reported CIPN, standing and dynamic balance, mobility, quality of life, and sensory and motor nerve excitability and conduction studies. Results Twenty-nine cancer survivors (8 male, 21 female; mean age 61.6 +/- 11.8 years) with CIPN symptoms affecting function completed all assessments. Objective and patient-reported CIPN, dynamic balance, standing balance in eyes open conditions, mobility and quality of life were improved from pre- to post-exercise (4.0 < F < 10.2; p < .05), with no changes over the control period (p > .21). No changes were observed in sensory or motor neurophysiologic parameters (p > .23). Conclusions This study provides encouraging evidence of the rehabilitative potential of multimodal exercise for persisting CIPN in a post-treatment cohort. Large randomised controlled trials are justified to confirm observed benefits and determine the mechanisms and clinical significance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available